Traders Purchase High Volume of Put Options on SPDR S&P Biotech ETF (NYSEARCA:XBI)

SPDR S&P Biotech ETF (NYSEARCA:XBI) was the target of some unusual options trading on Monday. Stock traders purchased 129,202 put options on the company. This is an increase of 39% compared to the typical volume of 92,783 put options.

SPDR S&P Biotech ETF Trading Down 0.8 %

Shares of NYSEARCA XBI opened at $85.62 on Wednesday. SPDR S&P Biotech ETF has a 1-year low of $63.80 and a 1-year high of $103.52. The company has a 50-day moving average of $93.86 and a two-hundred day moving average of $84.12. The company has a market cap of $6.65 billion, a PE ratio of 11.47 and a beta of 1.08.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of XBI. Concourse Financial Group Securities Inc. increased its stake in shares of SPDR S&P Biotech ETF by 21.2% in the 4th quarter. Concourse Financial Group Securities Inc. now owns 658 shares of the exchange traded fund’s stock valued at $59,000 after buying an additional 115 shares during the period. Farther Finance Advisors LLC boosted its holdings in SPDR S&P Biotech ETF by 26.0% in the second quarter. Farther Finance Advisors LLC now owns 630 shares of the exchange traded fund’s stock valued at $52,000 after acquiring an additional 130 shares during the last quarter. Verity Asset Management Inc. boosted its holdings in SPDR S&P Biotech ETF by 0.8% in the fourth quarter. Verity Asset Management Inc. now owns 17,368 shares of the exchange traded fund’s stock valued at $1,551,000 after acquiring an additional 140 shares during the last quarter. James J. Burns & Company LLC boosted its stake in shares of SPDR S&P Biotech ETF by 5.0% in the 3rd quarter. James J. Burns & Company LLC now owns 3,062 shares of the exchange traded fund’s stock valued at $224,000 after purchasing an additional 146 shares during the last quarter. Finally, Greenwich Wealth Management LLC grew its holdings in SPDR S&P Biotech ETF by 1.4% during the 4th quarter. Greenwich Wealth Management LLC now owns 11,451 shares of the exchange traded fund’s stock worth $1,022,000 after acquiring an additional 155 shares during the period.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.